Abstract

PURPOSE OF REVIEW
To provide an overview of the current research on renal tissue ablation, highlighting novel ablation techniques and technologies.
RECENT FINDINGS
As long-term data on renal radio frequency ablation (RFA) and cryoablation confirming their oncologic efficacy emerge, ongoing research aims at improving the treatment profiles of these techniques as well as developing novel methods for renal tissue ablation.
SUMMARY
Although nephron-sparing surgery is the gold standard treatment for small renal masses confirmed malignant, ablative therapies are an option in elderly patients, who may be poor surgical candidates. RFA and cryoablation have each been used for renal tissue ablation for over a decade but their efficacy in ablation of central lesions or lesions more than 3 cm in size is limited. Increasing ablation size and improving efficiency of thermal energy delivery are the goals of research in RFA and cryoablation. Novel ablation technologies including microwave ablation, irreversible electroporation and high-intensity focused ultrasound among others have undergone preliminary preclinical and clinical evaluation in select series but require further development and assessment of outcomes prior to routine clinical use for renal tumor ablation.

Links

Publisher Full Text

Authors

Olweny EO, Cadeddu JA

Institution

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA.

Source

Current opinion in urology 22:5 2012 Sep pg 379-84

MeSH

Ablation Techniques
Catheter Ablation
Cryosurgery
Electrochemotherapy
High-Intensity Focused Ultrasound Ablation
Humans
Kidney Diseases
Kidney Neoplasms
Treatment Outcome

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22706069